Stable isotope studies show differences in effect of insulin detemir and NPH insulin on hepatic glucose output and peripheral glucose uptake after subcutaneous administration in subjects with type1 diabetes

被引：0
|
作者：
Hordern, VM
Wright, JE
Umpleby, M
Jacobsen, L
Draeger, E
Russell-Jones, DL
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1187
引用
收藏
页码：A292 / A292
页数：1
相关论文
共 50 条
  • [11] Effect of subcutaneous insulin detemir on glucose flux and lipolysis during hyperglycaemia in people with type 1 diabetes
    Herring, R. A.
    Shojaee-Moradie, F.
    Umpleby, A. M.
    Jones, R.
    Jackson, N.
    Russell-Jones, D. L.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (05): : 459 - 467
  • [12] Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes
    Kolendorf, K.
    Ross, G. P.
    Pavlic-Renar, I.
    Perriello, G.
    Philotheou, A.
    Jendle, J.
    Gall, M-A.
    Heller, S. R.
    [J]. DIABETIC MEDICINE, 2006, 23 (07) : 729 - 735
  • [13] Effect of Subcutaneous Insulin Detemir on Glucose Flux, Lipolysis, and Electroencephalography during Euglycemia and Hyperglycemia in People with Type 1 Diabetes
    Herring, Roselle
    Knight, Richard
    Shojaee-Moradie, Fariba
    Johnsen, Sigurd
    Jackson, Nicola
    Umpleby, Margot
    Jones, Richard
    Dijk, Derk-Jan
    Russell-Jones, David
    [J]. DIABETES, 2015, 64 : A711 - A711
  • [14] Effect of combined application insulin and insulin detemir on continous glucose monitor in children with type 1 diabetes mellitus
    Chen, Xiao-Yun
    Dong, Qing
    Li, Gui-Mei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 4287 - 4291
  • [15] Use of the Site of Subcutaneous Insulin Administration for the Measurement of Glucose in Patients With Type 1 Diabetes
    Lindpointner, Stefan
    Korsatko, Stefan
    Koehler, Gerd
    Koehler, Hans
    Schaller, Roland
    Kaidar, Ruthy
    Yodfat, Ofer
    Schaupp, Lukas
    Ellmerer, Martin
    Pieber, Thomas R.
    Regittnig, Werner
    [J]. DIABETES CARE, 2010, 33 (03) : 595 - 601
  • [16] PS1 - 1. Insulin detemir increases cerebral glucose metabolism compared to NPH insulin in human type 1 diabetes: possible explanation for differences in weight gain?
    Larissa W. van Golen
    Marc C. Huisman
    Richard G. IJzerman
    Nikie J. Hoetjes
    Lothar A. Schwarte
    Patrick Schober
    Roel P. Hoogma
    Madeleine L. Drent
    Adriaan A. Lammertsma
    Michaela Diamant
    [J]. Nederlands Tijdschrift voor Diabetologie, 2011, 9 (3) : 91 - 91
  • [17] The effects of subcutaneous neutral protamine Hagedorn (NPH) insulin on glucose metabolism following a period of insulin withdrawal in patients with Type 1 diabetes
    Herring, R.
    Shojaee-Moradie, F.
    Jackson, N.
    Jones, R.
    Umpleby, A. M.
    Russell-Jones, D. L.
    [J]. DIABETIC MEDICINE, 2013, 30 : 15 - 16
  • [18] Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes
    Derosa, G.
    Franzetti, I.
    Querci, F.
    Romano, D.
    D'Angelo, A.
    Maffioli, P.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (06): : 554 - 559
  • [19] Within-person variation in fasting blood glucose is correlated to incidence of hypoglyacernia in people with Type 1 diabetes treated with insulin detemir and NPH insulin
    Heller, S
    Kim, H
    Draeger, E
    [J]. DIABETOLOGIA, 2004, 47 : A303 - A303
  • [20] Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes
    Bolli, G. B.
    Songini, M.
    Trovati, M.
    Del Prato, S.
    Ghirlanda, G.
    Cordera, R.
    Trevisan, R.
    Riccardi, G.
    Noacco, C.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (08) : 571 - 579
12345